BioCentury
ARTICLE | Product Development

Warp Speed accelerating mAbs, bullish on convalescent plasma for COVID-19

July 14, 2020 2:03 AM UTC

The U.S. government is accelerating the development of two forms of passive immunity for COVID-19 -- mAbs and convalescent plasma -- as well as antiviral, immune-modulating and anticoagulation agents, Janet Woodcock and a senior government official said Monday.

Although Operation Warp Speed is accelerating vaccine development, it is also prioritizing therapeutics because they could be ready for deployment more quickly, and because they will be needed to fill gaps caused by vaccines that are not 100% protective and from incomplete vaccination levels. ...